Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes - PubMed
Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes
Michele Dalla Vestra et al. Diabetes. 2003 Apr.
Abstract
Podocyte structural changes have been suggested to be involved in the pathogenesis of albuminuria in diabetes. We evaluated podocytes density, number, and structure in 67 white patients with type 2 diabetes: 21 normoalbuminuric (NA), 23 microalbuminuric (MA), and 23 proteinuric (P). Kidney function and biopsy studies were performed; 20 kidney donors served as control subjects. Electron microscopic morphometric analysis was used to estimate numerical density of podocytes per glomerulus [Nv(epi/glom)], filtration slit length density per glomerulus (FSLv/glom), and foot process width (FPW). The number of podocytes per glomerulus (Epi N/glom) was obtained by multiplying Nv(epi/glom) by mean glomerular volume. Nv(epi/glom) was significantly decreased in all type 2 diabetic groups compared with control subjects and was lower in MA and P than in NA (P < 0.0001, ANOVA). Epi N/glom was lower in MA and P patients compared with control subjects (P < 0.002, ANOVA); however, there were no significant differences among the type 2 diabetic groups. In addition, MA and P had decreased FSLv/glom and increased FPW compared with NA (P < 0.005 for both, ANOVA). The albumin excretion rate was inversely related to Nv(epi/glom) and FSLv/glom and directly to FPW (P < 0.0005 for all), whereas there was no correlation with Epi N/glom. In conclusion, changes in podocyte structure and density occur since the early stages of diabetic nephropathy and might contribute to increasing albuminuria in type 2 diabetic patients. These findings also suggest that in white type 2 diabetic patients, the density of podocytes may be functionally more relevant than the absolute number.
Similar articles
-
Structural involvement in type 1 and type 2 diabetic nephropathy.
Dalla Vestra M, Saller A, Bortoloso E, Mauer M, Fioretto P. Dalla Vestra M, et al. Diabetes Metab. 2000 Jul;26 Suppl 4:8-14. Diabetes Metab. 2000. PMID: 10922968 Review.
-
Moriya T, Moriya R, Yajima Y, Steffes MW, Mauer M. Moriya T, et al. Nephron. 2002 Jun;91(2):292-9. doi: 10.1159/000058407. Nephron. 2002. PMID: 12053068
-
Toyoda M, Najafian B, Kim Y, Caramori ML, Mauer M. Toyoda M, et al. Diabetes. 2007 Aug;56(8):2155-60. doi: 10.2337/db07-0019. Epub 2007 May 29. Diabetes. 2007. PMID: 17536064
-
Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate.
Nosadini R, Velussi M, Brocco E, Bruseghin M, Abaterusso C, Saller A, Dalla Vestra M, Carraro A, Bortoloso E, Sambataro M, Barzon I, Frigato F, Muollo B, Chiesura-Corona M, Pacini G, Baggio B, Piarulli F, Sfriso A, Fioretto P. Nosadini R, et al. Diabetes. 2000 Mar;49(3):476-84. doi: 10.2337/diabetes.49.3.476. Diabetes. 2000. PMID: 10868971
-
Wolf G, Chen S, Ziyadeh FN. Wolf G, et al. Diabetes. 2005 Jun;54(6):1626-34. doi: 10.2337/diabetes.54.6.1626. Diabetes. 2005. PMID: 15919782 Review.
Cited by
-
Susceptibility of podocytes to palmitic acid is regulated by stearoyl-CoA desaturases 1 and 2.
Sieber J, Weins A, Kampe K, Gruber S, Lindenmeyer MT, Cohen CD, Orellana JM, Mundel P, Jehle AW. Sieber J, et al. Am J Pathol. 2013 Sep;183(3):735-44. doi: 10.1016/j.ajpath.2013.05.023. Epub 2013 Jul 16. Am J Pathol. 2013. PMID: 23867797 Free PMC article.
-
Growth-dependent podocyte failure causes glomerulosclerosis.
Fukuda A, Chowdhury MA, Venkatareddy MP, Wang SQ, Nishizono R, Suzuki T, Wickman LT, Wiggins JE, Muchayi T, Fingar D, Shedden KA, Inoki K, Wiggins RC. Fukuda A, et al. J Am Soc Nephrol. 2012 Aug;23(8):1351-63. doi: 10.1681/ASN.2012030271. Epub 2012 Jul 5. J Am Soc Nephrol. 2012. PMID: 22773827 Free PMC article.
-
Kim DK, Nam BY, Li JJ, Park JT, Lee SH, Kim DH, Kim JY, Kang HY, Han SH, Yoo TH, Han DS, Kang SW. Kim DK, et al. Diabetologia. 2012 Apr;55(4):1205-17. doi: 10.1007/s00125-012-2467-7. Epub 2012 Feb 4. Diabetologia. 2012. PMID: 22311416
-
Podocyte Depletion in Thin GBM and Alport Syndrome.
Wickman L, Hodgin JB, Wang SQ, Afshinnia F, Kershaw D, Wiggins RC. Wickman L, et al. PLoS One. 2016 May 18;11(5):e0155255. doi: 10.1371/journal.pone.0155255. eCollection 2016. PLoS One. 2016. PMID: 27192434 Free PMC article.
-
Effects of BSF on Podocyte Apoptosis via Regulating the ROS-Mediated PI3K/AKT Pathway in DN.
Cui FQ, Wang YF, Gao YB, Meng Y, Cai Z, Shen C, Liu ZQ, Jiang XC, Zhao WJ. Cui FQ, et al. J Diabetes Res. 2019 Dec 7;2019:9512406. doi: 10.1155/2019/9512406. eCollection 2019. J Diabetes Res. 2019. PMID: 31886291 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical